Tissue factor and tissue factor pathway inhibitorPRICE, G. C; THOMPSON, S. A; KAM, P. C. A et al.Anaesthesia. 2004, Vol 59, Num 5, pp 483-492, issn 0003-2409, 10 p.Article

Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPsUSZYNSKI, Mieczysław; ZEKANOWSKA, Ewa; USZYNSKI, Waldemar et al.European journal of obstetrics, gynecology, and reproductive biology. 2011, Vol 158, Num 1, pp 37-41, issn 0301-2115, 5 p.Article

Mechanisms of autoantibody-induced monocyte tissue factor expressionWOLBERG, Alisa S; ROUBEY, Robert A. S.Thrombosis research. 2004, Vol 114, Num 5-6, pp 391-396, issn 0049-3848, 6 p.Conference Paper

Sources of tissue factorØSTERUD, Bjarne; BJØRKLID, Eirik.Seminars in thrombosis and hemostasis. 2006, Vol 32, Num 1, pp 11-23, issn 0094-6176, 13 p.Article

Formation of tissue factor-bearing leukocytes during and after cardiopulmonary bypassSHIBAMIYA, Aya; TABUCHI, Noriyuki; LIHWA CHUNG et al.Thrombosis and haemostasis. 2004, Vol 92, Num 1, pp 124-131, issn 0340-6245, 8 p.Article

Role of PDI in regulating tissue factor: FVIIa activityPOPESCU, Narcis I; LUPU, Cristina; LUPU, Florea et al.Thrombosis research. 2010, Vol 125, issn 0049-3848, S38-S41, SUP1Article

Analysis of tissue factor positive microparticlesKEY, Nigel S.Thrombosis research. 2010, Vol 125, issn 0049-3848, S42-S45, SUP1Article

Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromesGOLINO, Paolo; RAVERA, Amelia; RAGNI, Massimo et al.Circulation (New York, N.Y.). 2003, Vol 108, Num 23, pp 2864-2869, issn 0009-7322, 6 p.Article

The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactionsLIAN ZHAO; BATH, Philip M. W; FOX, Sue et al.Current medical research and opinion. 2003, Vol 19, Num 3, pp 178-186, issn 0300-7995, 9 p.Article

Tissue specific expression and serum levels of human tissue factor in patients with urological cancerFÖRSTER, Yvonne; MEYE, Axel; ALBRECHT, Sybille et al.Cancer letters. 2003, Vol 193, Num 1, pp 65-73, issn 0304-3835, 9 p.Article

Pharmacological inhibition of tissue factorLATERRE, Pierre-Francois; WITTEBOLE, Xavier; COLLIENNE, Christine et al.Seminars in thrombosis and hemostasis. 2006, Vol 32, Num 1, pp 71-76, issn 0094-6176, 6 p.Article

Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental hemostasisAHARON, Anat; BRENNER, Benjamin; KATZ, Tamar et al.Thrombosis and haemostasis. 2004, Vol 92, Num 4, pp 776-786, issn 0340-6245, 11 p.Article

Tissue factor pathway inhibitor production by human proximal tubular epithelial cells in cultureSUGAWARA, Toshiyuki; YAMABE, Hideaki; OSAWA, Hiroshi et al.Thrombosis research. 2003, Vol 110, Num 2-3, pp 141-147, issn 0049-3848, 7 p.Article

Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patientsGANDO, Satoshi; KAMEUE, Takashi; MATSUDA, Naoyuki et al.Thrombosis research. 2003, Vol 109, Num 2-3, pp 119-124, issn 0049-3848, 6 p.Article

Interdependent biological systems, multi-functional molecules: The evolving role of tissue factor pathway inhibitor beyond anti-coagulationHOLROYD, Eric W; SIMARI, Robert D.Thrombosis research. 2010, Vol 125, issn 0049-3848, S57-S59, SUP1Article

Prostasomes, angiogenesis, and tissue factorDELVES, George H; STEWART, Alistair B; COOPER, Alan J et al.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 1, pp 75-79, issn 0094-6176, 5 p.Article

Novel peptides that inhibit heparanase activation of the coagulation systemAXELMAN, Elena; HENIG, Israel; CRISPEL, Yonatan et al.Thrombosis and haemostasis. 2014, Vol 112, Num 3, pp 466-477, issn 0340-6245, 12 p.Article

Posttranslational modifications and activity of natural and recombinant tissue factorBUTENAS, Saulius; KRUDYSZ-AMBLO, Jolanta; MANN, Kenneth G et al.Thrombosis research. 2010, Vol 125, issn 0049-3848, S26-S28, SUP1Article

The effects of twelve representative flavonoids on tissue factor expression in human monocytes: Structure-activity relationshipsWENWEN JIANG; JUNPING KOU; ZHI ZHANG et al.Thrombosis research. 2009, Vol 124, Num 6, pp 714-720, issn 0049-3848, 7 p.Article

Protein disulfide isomerase has no stimulatory chaperone effect on factor X activation by factor VIIa-soluble tissue factorPERSSON, Egon.Thrombosis research. 2008, Vol 123, Num 1, pp 171-176, issn 0049-3848, 6 p.Article

Tissue factor expression in blood cellsØSTERUD, Bjarne.Thrombosis research. 2010, Vol 125, issn 0049-3848, S31-S34, SUP1Article

LPS induced tissue factor expression in the THP-1 monocyte cell line is attenuated by conjugated linoleic acidNORRIS, Lucy A; WELDON, Sinead; NUGENT, Anne et al.Thrombosis research. 2006, Vol 117, Num 4, pp 475-480, issn 0049-3848, 6 p.Article

Filamin-A is required for the incorporation of tissue factor into cell-derived microvesiclesCOLLIER, Mary E. W; MARAVEYAS, Anthony; ETTELAIE, Camille et al.Thrombosis and haemostasis. 2014, Vol 111, Num 4, pp 647-655, issn 0340-6245, 9 p.Article

Modification of the lipidic and coagulative pattern in postmenopause women: effect of hormone replacement therapyEVOLA, G; NOVO, G; NOVO, S et al.International angiology. 2010, Vol 29, Num 4, pp 355-361, issn 0392-9590, 7 p.Article

Suppression of HUVEC tissue factor synthesis by antisense oligodeoxynucleotideSTEPHENS, Alick C; RANLALL, Nancy F; RIVERS, Rodney P. A et al.Thrombosis research. 2008, Vol 122, Num 1, pp 99-107, issn 0049-3848, 9 p.Article